Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance

Generated: March 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087666

« Back to Dashboard

NDA 087666 describes SULFINPYRAZONE, which is a drug marketed by Barr, Ivax Pharms, Par Pharm, Vangard, and Watson Labs, and is included in eight NDAs. Additional details are available on the SULFINPYRAZONE profile page.

The generic ingredient in SULFINPYRAZONE is sulfinpyrazone. There are four drug master file entries for this compound. Additional details are available on the sulfinpyrazone profile page.
Summary for 087666
Therapeutic Class:Antigout Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 087666

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength200MG
Approval Date:Sep 17, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.